论文部分内容阅读
目的探讨乳腺癌患者的临床病理特点。方法回顾性分析汝州市第一人民医院收治的76例乳腺癌患者的病理特点,患者均以手术治疗为主,术后辅助化疗、放疗。手术标本的ER、PR、C-erbB-2检测采用免疫组织化学方法。结果 76例乳腺癌患者ER、PR及CerbB-2的阳性率分别为65.8%、64.5%及67.1%,ER、PR随年龄的增加呈显著增加(P<0.05),C-erbB-2与乳腺癌的发病年龄无相关性(P>0.05)。结论 ER、PR与乳腺癌患者年龄称正相关,早发现、早诊断及科学治疗乳腺癌对乳腺癌患者的预后有重要意义。
Objective To investigate the clinicopathological features of breast cancer patients. Methods A retrospective analysis of Ruzhou First People’s Hospital of 76 cases of breast cancer patients with pathological features, the patients were treated mainly postoperative adjuvant chemotherapy and radiotherapy. Surgical specimens of the ER, PR, C-erbB-2 detection using immunohistochemical methods. Results The positive rates of ER, PR and CerbB-2 in breast cancer patients were 65.8%, 64.5% and 67.1%, respectively. The ER, PR increased with age (P <0.05) The age of onset of cancer had no correlation (P> 0.05). Conclusions ER and PR are positively correlated with the age of breast cancer patients. Early detection, early diagnosis and scientific treatment of breast cancer are of great significance for the prognosis of patients with breast cancer.